Long-term outcomes of pediatric heart transplantation in single-ventricle heart disease: A single-center analysis.

Objective and Aims: Pediatric heart transplantation (HTx) for children with single-ventricle (SV) physiology remains a complex and high-risk procedure. This study aimed to retrospectively evaluate long-term outcomes in patients with SV undergoing primary HTx versus HTx after failed staged palliation...

Descripción completa

Detalles Bibliográficos
Publicado en:Annals of Pediatric Cardiology Vol. 18; no. 6; pp. 541 - 551
Autores principales: Rosenthal, L. Lily, Netz, Heinrich, Haas, Nikolaus A., Grinninger, Carola, Hörer, Jörgen, Michel, Sebastian, Hagl, Christian, Fischer, Marcus
Formato: research tables/charts Journal Article
Publicado: Wolters Kluwer India Pvt Ltd Nov/Dec2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=192310396&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 192310396
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09742069
        589G
      jtl: Annals of Pediatric Cardiology
      issn: 09742069
      maglogo: N
    pubinfo:
      dt: Nov/Dec2025
      vid: 18
      iid: 6
      pid: 16919
      pub: Wolters Kluwer India Pvt Ltd
    artinfo:
      ui:
        192310396
        192310396
        192310396
        10.4103/apc.apc_209_25
        192310396
      ppf: 541
      ppct: 10
      formats:
      tig:
        atl: Long-term outcomes of pediatric heart transplantation in single-ventricle heart disease: A single-center analysis.
      aug:
        au:
          Rosenthal, L. Lily
          Netz, Heinrich
          Haas, Nikolaus A.
          Grinninger, Carola
          Hörer, Jörgen
          Michel, Sebastian
          Hagl, Christian
          Fischer, Marcus
        affil: Division for Pediatric and Congenital Heart Surgery, LMU University Hospital Munich, Munich, Germany
      sug:
        subj:
          Heart Septal Defects, Ventricular
          Heart Transplantation
          Pediatric Surgery
          Heart Defects, Congenital
          Treatment Outcomes
          Hypoplastic Left Heart Syndrome
          Treatment Failure
          Human
          Male
          Female
          Retrospective Design
          Palliative Care
          Survival Rate
          Descriptive Statistics
          Cytomegaloviruses
          Epstein-Barr Virus Infections
          Confidence Intervals
          Descriptive Research
          T-Tests
          Fisher's Exact Test
          Chi Square Test
          Data Analysis Software
          Extracorporeal Membrane Oxygenation
          Infant, Newborn
          Infant
          Child, Preschool
          Child
          Adolescence
          Infant, Newborn: birth-1 month
          Infant: 1-23 months
          Child, Preschool: 2-5 years
          Child: 6-12 years
          Adolescent: 13-18 years
          Male
          Female
      ab: Objective and Aims: Pediatric heart transplantation (HTx) for children with single-ventricle (SV) physiology remains a complex and high-risk procedure. This study aimed to retrospectively evaluate long-term outcomes in patients with SV undergoing primary HTx versus HTx after failed staged palliation. Methods: Between 1991 and 2025, 22 pediatric patients (aged ≤ 18 years) with SV physiology underwent orthotopic HTx. Thirteen received primary HTx (Group 1), and nine had HTx after failed staged palliation (Group 2), including two post-Norwood, three post-Glenn, and four post-Fontan procedures. Results: The 10-year survival rate was 71.6%, with similar re-transplant-free survival. The median transplant age was 0.22 years (interquartile range [IQR], 0.08–0.49) for Group 1 and 15.1 years (IQR, 3.0–16.5) for Group 2. Posttransplant extracorporeal membrane oxygenation was needed in three patients in Group 1 and six patients in Group 2. Coronary vasculopathy (grades I–III) occurred in eight patients in Group 1 and 5 patients in Group 2; one patient in each group underwent re-HTx. Cytomegalovirus positivity was found in three and one patients; Epstein–Barr virus positivity in six and two patients (Groups 1 and 2, respectively). Rejection (grades 0–II) occurred in 7 and 2 patients, respectively. Posttransplant lymphatic disorder developed in four patients (Group 1). Immunosuppression was changed in 10 patients (Group 1) and 6 patients (Group 2). Three patients in Group 1 required pacemakers. Conclusions: HTx is feasible for pediatric SV patients. Primary Tx in infancy may involve shorter operative times, whereas HTx after failed palliation, especially post-Fontan, is more complex and associated with higher morbidity. Early referral and tailored treatment are essential. Multicenter prospective studies are needed to improve patient selection and address donor availability.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N